Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 9,010 shares at $54.67 ($493K) on 2007-10-15, disclosed to the SEC on 2007-10-16.
Scheduled sale ($493k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.61 | 1,118 | $61K | 12.4% |
| 2 | $54.62 | 86 | $5K | 1.0% |
| 3 | $54.67 | 2,322 | $127K | 25.7% |
| 4 | $54.68 | 602 | $33K | 6.7% |
| 5 | $54.69 | 344 | $19K | 3.8% |
| 6 | $54.71 | 258 |
| $14K |
| 2.9% |
| 7 | $54.73 | 860 | $47K | 9.5% |
| 8 | $54.75 | 168 | $9K | 1.9% |
| 9 | $54.81 | 770 | $42K | 8.6% |
| 10 | $54.82 | 86 | $5K | 1.0% |
| 11 | $54.89 | 516 | $28K | 5.7% |
| 12 | $54.90 | 344 | $19K | 3.8% |
| 13 | $54.93 | 15 | $824 | 0.2% |
| 14 | $54.94 | 688 | $38K | 7.7% |
| 15 | $54.95 | 833 | $46K | 9.3% |
| Total | $54.75 avg | 9,010 | $493K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |